Page last updated: 2024-10-30

pyrrolidine-2,4-dicarboxylic acid and Seizures

pyrrolidine-2,4-dicarboxylic acid has been researched along with Seizures in 1 studies

pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"These findings indicate that seizures are not necessarily accompanied by an increased extracellular glutamate level and that increased glutamatergic excitation in epilepsy may result from other abnormalities such as increased density of glutamate receptors, enhanced activation subsequent to reduced modulation, or sprouting of glutamatergic synapses."1.29Evidence disputing the link between seizure activity and high extracellular glutamate. ( Obrenovitch, TP; Urenjak, J; Zilkha, E, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Obrenovitch, TP1
Urenjak, J1
Zilkha, E1

Other Studies

1 other study available for pyrrolidine-2,4-dicarboxylic acid and Seizures

ArticleYear
Evidence disputing the link between seizure activity and high extracellular glutamate.
    Journal of neurochemistry, 1996, Volume: 66, Issue:6

    Topics: Animals; Dicarboxylic Acids; Electroencephalography; Electrophysiology; Excitatory Amino Acid Antago

1996